Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CnU Cap. 750 mg in Patients With Cholesterol Gallstone
NCT07005752Phase 4Recruiting
- Sponsor
- Myungmoon Pharm
- Start
- Jul 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of CnU in cholelithiasis, sponsored by Myungmoon Pharm. Started Jul 2025; status: recruiting.
02
Drugs
CnU
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT07005752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07005752.